📚 Wiki Growth Hormone CJC-1295 No-DAC

CJC-1295 No-DAC

● Preclinical / Research
Modified GRF(1-29), CJC-1295 Without Drug Affinity Complex
Also known as: Mod GRF 1-29, Modified GRF, CJC-1295 (no DAC), GRF(1-29)
Brand names: Modified GRF 1-29 (research grade), Mod GRF
Page last reviewed

Quick Summary

CJC-1295 No-DAC (also called Modified GRF 1-29 or Mod GRF) is a short-acting GHRH (Growth Hormone-Releasing Hormone) analog consisting of the first 29 amino acids of endogenous GHRH with four amino acid substitutions to improve stability and receptor binding.

Growth Hormone & IGF Research Use WADA Prohibited
CJC-1295 No-DAC (also called Modified GRF 1-29 or Mod GRF) is a short-acting GHRH (Growth Hormone-Releasing Hormone) analog consisting of the first 29 amino acids of endogenous GHRH with four amino acid substitutions to improve stability and receptor binding. Unlike CJC-1295 with DAC, it has a half-life of only 30 minutes and produces a sharp, pulsatile GH release, mimicking the natural GH secretion pattern. It is most commonly stacked with GHRP peptides (Ipamorelin, GHRP-6) for synergistic GH release.
Storage Stability
Lyophilized
1–2 years (-20°C)
Reconstituted
~30 days (2–8°C)
Room temp
Avoid

Mechanism of Action

GHRH Receptor Agonism

Mod GRF 1-29 binds the GHRH receptor on pituitary somatotrophs, stimulating cAMP production and triggering GH synthesis and secretion. It amplifies the somatotroph's responsiveness to endogenous GHRH pulses.

Pulsatile GH Pattern

Because of its short half-life (~30 min), Mod GRF produces a sharp GH spike within 15–30 minutes of injection, then clears. This preserves the natural pulsatile pattern of GH release, unlike long-acting GHRH analogs that cause sustained elevation.

Synergy with GHRPs

GHRH and GHRP peptides act on different receptor systems. When combined (e.g., Mod GRF + Ipamorelin), GH output is 2–10x greater than either compound alone, the synergy is well-documented in multiple studies.

Research Summary

GH Pulse Amplification

Studies confirm Mod GRF 1-29 significantly increases GH amplitude of natural pulses. In combination with Ipamorelin, mean GH secretion increases 5–10 fold in animal models.

IGF-1 Elevation

With regular use, elevated GH pulses drive sustained IGF-1 elevation, which mediates the anabolic and recovery effects.

Safety

As a natural GHRH analog that amplifies existing pituitary function rather than bypassing it, Mod GRF is considered lower-risk than exogenous GH. Somatostatin feedback mechanisms remain intact.

Calculate your CJC-1295 No-DAC dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →

Research Protocols

GHRP Stack (most common)

Inject Mod GRF 1-29 (100–200 µg) with Ipamorelin (200–300 µg) simultaneously, 2–3x daily. Morning fasted + pre-sleep are the two highest-priority injection times.

Timing

Dose within 30 minutes of eating to avoid GH blunting from elevated insulin/glucose. Best results when fasted.

Cycle

8–12 weeks on, then 4–8 weeks off to maintain pituitary sensitivity.

Storage & Handling

Keep lyophilized" class="wiki-gloss-link">lyophilized powder frozen (-20°C). Reconstitute with bacteriostatic water. Store reconstituted solution at 2–8°C for up to 30 days. Mod GRF is fragile, avoid vigorous shaking and multiple freeze-thaw cycles.


References

  • [1]Alba M, et al. "Once-daily administration of CJC-1295 in healthy adults." J Clin Endocrinol Metab, 2006.
  • [2]Bowers CY, et al. "Synergistic release of GH by GHRH and GHRP." Endocrinology, 1990.
Ready to dose CJC-1295 No-DAC?
Get the exact syringe draw
You have read the research. Now run the math. Pick your vial size and BAC water volume, get IU draw in seconds.
Open the Calculator →
PK Plotter · half-life ~30 min
Visualize CJC-1295 No-DAC plasma levels over time → Plot →
Verified Scientific Data Last audited:
Data Sources & External References
Source: peer-reviewed literature  ·  Domain: ascendpeptide.org
CJC-1295 No-DAC
Peptide calculator, vial + dose → draw volume
Dose CJC-1295 No-DAC →

Suggest a Change

CJC-1295 No-DAC · wiki page